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CalcinosisAbstract Aim of the work: To compare ultrasonographic (US) hand features in systemic sclerosis
(SSc) and rheumatoid arthritis (RA) patients and to investigate their relationship with disease
activity, clinical and radiographic data.
Patients and methods: Forty SSc and 30 RA patients were consecutively included. All patients
underwent clinical examination, X-ray and US on the hand and wrist joints to detect synovitis,
tenosynovitis, and calcinosis. Disease activity score-28 (DAS28) and European Scleroderma
Activity index were used for RA and SSc patients respectively. Health Assessment Question-
naire-Disability Index (HAQ-DI) was used in all patients.
Results: The frequency of synovitis and tenosynovitis detected by US was found to be higher
than that found by clinical examination in both RA and SSc patients (p= 0.01, p= 0.02, respec-
tively). US synovitis was detected in 10 SSc (25%) and in 17 RA patients (56%). US tenosynovitis
was found in 18 SSc (45%) versus 11 RA patients (36.6%). US synovitis and tenosynovitis in RA
patients showed a statistically signiﬁcant correlation with the erythrocyte sedimentation rate (ESR),
C-reactive protein (CRP), rheumatoid factor, HAQ-DI and DAS28. Positive intrasynovial power
Doppler signal was signiﬁcantly frequent in RA than SSc patients (p< 0.001). Sclerosing tenosyn-
ovitis appeared to be speciﬁc to SSc patients. Calciﬁcations were observed in both SSc and RA
patients, but with no statistically signiﬁcant difference (p= 0.69).
Conclusion: US provided valuable disease activity information in both RA and SSc patients
more than clinical examination. US articular involvement in SSc is less frequent compared to that
in RA, with speciﬁc appearance of sclerosing tenosynovitis in SSc patients.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic Diseases.
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Musculoskeletal ultrasound (MSUS) nowadays plays an
important role in diagnosing and treating rheumatic diseases
[1]. The presence of synovitis detected by MSUS is useful in
the diagnosis of undifferentiated arthritis (UA) [2] and in
inﬂammatory arthritis it is predictive of persistent disease [3],
joint damage [4], and acute disease ﬂare [5]. It has dramatically
improved joint and tendon evaluation in rheumatoid arthritis
(RA) and other inﬂammatory diseases [6]. However, MSUS
also has its limitations as the technique is operator dependant,
and assessments are time consuming if a large number of joints
are examined.
In RA, MSUS is more sensitive than clinical examination
for detecting synovitis [7,8] and the presence of MSUS synovi-
tis correlates with future radiographic progression [9]. Conse-
quently, it has been suggested that MSUS should be
included in the deﬁnition of remission [10] and that MSUS
assessment of disease activity could be utilized to inform ther-
apeutic decisions as part of a treating to target strategy [11].
Regarding systemic sclerosis (SSc), joint symptoms are
reported by 24–97% of SSc patients during the course of their
disease, and are frequently disabling [12–16]. Manifestations of
SSc hand are ranging from arthralgias to frank arthritis, con-
tractures, and tendon friction rubs [12]. Clinical assessment is
limited by concomitant skin disease.
Radiographic studies in SSc and RA have shown that the
commonly affected areas are the joints, soft tissue, and bones
of the hands [13,14,17–19]. However, radiographs exhibit some
limitations regarding their sensitivity to detect early inﬂamma-
tory changes, such as effusion or synovitis, and they cannot
assess tendon damage. Therefore, radiographic and clinical
evaluations are imperfect for assessing the whole spectrum of
articular involvement in SSc and RA [6].
The objectives of our study were to compare the character-
istics of US hand involvement in SSc and RA patients and to
determine the correlations between US ﬁndings with disease
activity, clinical and radiological parameters.
2. Patients and methods
2.1. Study design
The work was conducted as a comparative study between ultr-
asonographic hand features in SSc and RA patients and to
study their relation to clinical and radiological ﬁndings. All
subjects were recruited from Rheumatology departments,
Cairo and Fayoum University hospitals and were all informed
about the study and a written informed consent was obtained
from each patient and healthy controls in accordance with the
ethical principles for human investigations, as outlined in the
2nd Helsinki Declaration.
2.2. Patients
We studied 40 SSc patients (30 females and 10 males) who ful-
ﬁlled ACR criteria [20] with a mean age of 34.4 ± 8.5 years,
together with 30 RA patients (22 females and 8 males) who sat-
isﬁed the 2010 ACR/EULAR criteria [21] with a mean age of
44.0 ± 9.4 years. The SSc patients were further subdividedinto diffuse (dSSc) and limited (lSSc) according to the criteria
proposed by Le Roy and his colleagues [22]. All patients were
assessed for sex, age, disease duration and medications taken.
For the disease activity measures, we used the disease activity
score-28 (DAS 28) for RA patients [23] and the European
Scleroderma Study Group activity index was used for SSc
patients [24]. The Health Assessment Questionnaire and
Disability Index (HAQ-DI) was used for both SSc and RA
patients [25].2.3. Laboratory data
The ESR was measured by the Westergren method; serum
CRP by nephelometry; Rheumatoid factor (RF) by latex test;
anti-cyclic citrullinated antibody (anti-CCP) by ELISA; and
Anticentromere antibodies and Anti nuclear antibodies
(ANA) by immunoﬂuorescent while anti-Scl70 by ELISA.2.4. Clinical assessment
Clinical evaluation on each patient was performed by 2
rheumatologists, blinded to the X-ray and US characteristics.
Tender and swollen joint counts, together with the presence
of tendon friction rubs and contractures were recorded [26].
2.5. X-ray evaluation
Standard antero-posterior views of the hands and wrists were
obtained from SSc and RA patients. The following features
were noticed for each joint: juxta-articular osteoporosis, space
narrowing, marginal and central erosions and deformity.
X-rays were evaluated by a radiologist blinded to the
identity of patients and to the clinical and ultrasonographic
characteristics.
2.6. US examination
US was performed on the joints of both hands and ﬁngers
(metacarpophalangeal [MCP], proximal interphalangeal
[PIP], and distal interphalangeal [DIP] joints) and the wrists
(radiocarpal [RC], ulnarcarpal [UC] and intercarpal [IC]
joints), with LOGIQ P5/A5/A5Pro ultrasound machine using
a near focused linear array transducer with a center frequency
of 10–14 MHz. US examination aimed at the detection of
synovitis, tenosynovitis and calcinosis. PD was graded using
a validated semiquantitative scoring system, which consists
of a scale of 0–3, where (0) represented no PD signal, (1) one
or two vessels in small joints or up to three single vessels in
large joints, (2) less than half of the synovial area and (3) more
than half of the synovial area [27].
Data analysis was performed through Statistical Package of
Social Sciences (SPSS) software program for windows version
21. Data were expressed as number and percentage for
qualitative variables or mean and standard deviation for
quantitative ones. Comparison between groups was performed
through the Chi square or Fisher’s exact test for qualitative
variables and independent sample t-test (if parametric) or the
Mann Whitney test (if non-parametric) for quantitative ones.
p values less than 0.05 were considered signiﬁcant.
Table 2 Radiologic articular involvement among systemic
sclerosis (SSc) and rheumatoid arthritis (RA) patients.*
SSc patients
(n= 40)
RA patients
(n= 30)
Radiologic demineralization 15 (37.5) 20 (66.7)
Joint space narrowing
Wrists 2 (5) 6 (20)
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The study included 40 SSc patients (30 females and 10 males),
25 had limited form and 15 had diffuse form with a mean age
of 34.4 ± 8.5 years and a mean disease duration of
5.2 ± 2.6 years in addition to 30 RA patients (22 females
and 8 males) with a mean age of 44.0 ± 9.4 years and a mean
disease duration of 6.8 ± 5.1 years. ANA was detected in 15
SSc patients while 20 were anti-centromere positive and 10
anti-Scl 70 positive. Rheumatoid factor (RF) was detected in
52% of the SSc patients and 85% in the RA patients while
anti-CCP was detected in 30% of RA patients and 2% in
SSc patients. The mean ESR and CRP in SSc patients was
20.2 ± 8.0 mm/h and 3.9 ± 4.8 mg/dl respectively, while in
RA patients the ESR and CRP were 30.2 ± 7.0 mm/h and
5.0 ± 6.8 mg/dl respectively. The mean DAS28 was
3.86 ± 2.17 and the HAQ-DI was 1.7 ± 0.8.
The treatment regimens for the RA patients were
DMARDs (Methotrexate, Leﬂunomide and Hydroxychloro-
quine) in 28/30 patients and steroids in 22/30 patients (mean
dosage 7.9 ± 5.9 mg/day). As for the SSc patients treatment
regimen included a low dose of steroids ranging between 5
and 10 mg in 18/40 patients, DMARDs mostly methotrexate
and azathioprine in 11/40 patients and cyclophosphamide in
5/40 patients.
MCP joints 3 (7.5) 15 (50)
PIP joints 1 (2.5) 10 (33.3)
Erosions
Wrists 1 (2.5) 8 (26.7)
MCP joints 0 (0) 12 (40)
PIP joints 0 (0) 9 (30)
Calcinosis 4 (10) 2 (6.7)
Acro-osteolysis 1 (2.5) 0 (0)
Osteophytes 1 (2.5) 3 (10)
SSc = systemic sclerosis; RA = rheumatoid arthritis; MCP=
metacarpophalangeal; PIP = proximal interphalangeal; DIP =
distal interphalangeal.
* Values are the number (percentage) unless otherwise indicated.3.1. Clinical features
Thirteen SSc patients (32.5%) had tender joints on palpa-
tion and 6 patients (15%) had swollen joints, in addition
tendon friction rubs were present in 11 SSc patients
(27.5%). Among RA patients, 19 (63.3%) had tender joints
on palpation and 13 patients (43.3%) had swollen joints
while tendon friction rub was present in 1 RA patient
(3.3%). The clinical articular features of the SSc and RA
patients are shown in (Table 1).Table 1 Clinical articular involvement and disability index among
SSc patients (n=
Patients with tender joints 13 (32.5)
Number of tender joints (mean ± SD) 1.9 ± 1.04
Distribution of tender joints
Wrist 2 (15.4)
MCP 8 (61.5)
PIP 8 (61.5)
DIP 0 (0.0)
Patients with P1 swollen joint 10 (25)
Number of swollen joints (mean ± SD) 1.4 ± 0.5
Distribution of the swollen joints
Wrist 1/10 (10)
MCP 9/10 (90)
PIP 4/10 (40)
DIP 0/10 (0)
Tendon friction rubs 11 (27.5)
HAQ-DI score (mean ± SD) 0.9 ± 0.8
SSc = systemic sclerosis; RA= rheumatoid arthritis; MCP=metacarp
phalangeal; HAQ-DI = Health Assessment Questionnaire-Disability inde
* Values are the number (percentage) unless otherwise indicated.3.2. Radiographic ﬁndings
The main radiographic features of hand involvement in our
study were as follows: among RA patients, bone erosions
involving the wrist in 8 (26.7%) patients, MCPs in 12 (40%)
of the patients and PIPs in 9 (30%) patients. Joint space nar-
rowing involving the wrist in 6 (20%) of the patients, MCPs in
15 (50%) of the patients and PIPs in 10 (33.3%) patients,
demineralization in 20 (66.7%), patients, calcinosis in 2
(6.6%) patients and osteophytes in 2 (6.6%). On the other
hand SSc patients found to have bone erosions in 1 (2.5%)
patient involving the wrist joint, joint space narrowing over
the wrist in 1 (5%) patient, MCPs in 3 (7.5%) patients and
PIPs in 1 (2.5%) patient. Demineralization in 15 (37.5%)
patients, acro-osteolysis in 1 (2.5%) patient and calcinosis in
4 (10%) patients (Table 2).systemic sclerosis (SSc) and rheumatoid arthritis (RA) patients.*
40) RA patients (n= 30) p Value
19 (63.3)
5.84 ± 3.96 0.015
14 (73.7)
14 (73.7)
11 (57.9)
2 (10.5)
16 (53.3)
6.5 ± 3.4 0.024
6/16 (37.5)
7/16 (43.8)
3/16 (18.8)
0/16 (0.0)
1 (3.3)
0.87 ± 0.88 0.009
ophalangeal; PIP = proximal interphalangeal; DIP = distal inter-
x.
Table 3 Comparison of ultrasonography ﬁndings between systemic sclerosis (SSc) and rheumatoid arthritis (RA) patients.*
SSc patients (n= 40) RA patients (n= 30) p-Value
Synovitis 10 (25) 17 (56) 0.044
Characteristics of synovitis
Inﬂammatory activity 3 (20) 57 (95) <0.001
Power Doppler grade 1 3 (20) 32 (53.3) 0.02
Power Doppler grade 2 or 3 0 (0) 25 (41.6) 0.002
Distribution of synovitis
Ulnarcarpal joints 0 (0) 8 (13.3) 0.3
Radiocarpal joints 1 (6.6) 11 (18.3) 0.4
Intercarpal joints 0 (0) 11 (18.3) 0.1
MCP joints 9 (60) 35 (58.3) 1.0
PIP joints 4 (26.6) 15 (25) 1.0
DIP joints 0 (0) 0 (0) 1.0
Tenosynovitis 18 (45) 11 (36.6) 0.63
Characteristics of tenosynovitis
Sclerosing pattern 81 (90) 0 (0) <0.001
Inﬂammatory activity 45 (50) 14 (87.5) 0.006
Sclerosing and inﬂammatory pattern 34 (37.7) 0 (0) 0.002
Distribution of tenosynovitis
No. of extensor tendons 44 6
Sclerosing pattern 42 (95.5) 0 (0) <0.001
Power Doppler 17 (38.6) 3 (50) 0.7
No. of ﬂexor tendons 46 10
Sclerosing pattern 39 (84.8) 0 (0) <0.001
Power Doppler 25 (54.3) 9 (90) 0.07
Calciﬁcations 4 (10) 2 (6.6) 0.7
In the tendon sheath 0 (0) 0 (0) –
Intraarticular 4 (100) 2 (100) –
In the soft tissue 0 (0) 0 (0) –
Osteophytes 4 (10) 6 (20) 1.0
Erosions
Wrists 1 (2.5) 10 (33) 0.003
MCPs 0 14 (46) 0.002
PIPs 0 10 (33) 0.001
Joint space narrowing
Wrists 4 (10) 8 (26)
MCPs 4 (10) 18 (60)
PIPs 1 (2.5) 10 (33)
SSc = systemic sclerosis; RA= rheumatoid arthritis; MCP =metacarpophalangeal; PIP = proximal interphalangeal; DIP = distal
interphalangeal.
* Values are number (percentage) unless otherwise indicated.
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The results of US ﬁndings in SSc versus RA patients are shown
in (Table 3).3.3.1. US synovitis in SSc and RA patients
Regarding synovitis (i.e. effusion and/or synovial prolifera-
tion) (Fig. 1), US detected synovitis in 10 (25%) of 40 SSc
patients and in 17 (56%) patients with RA, synovitis was
found in the wrists, MCP joints and PIP joints of SSc patients
with a statistically signiﬁcant difference when compared to the
RA patients (p= 0.04). Power Doppler revealed inﬂammatory
activity in 3 joints with synovitis in SSc patients, all of which
were of grade 1. Positive intrasynovial power Doppler signal
was signiﬁcantly frequent in RA than SSc patients (57/60 joints
[95%] versus 3/15 joints [20%], p< 0.001). A grade 2 or 3
power Doppler signal was more likely observed in RA thanin SSc patients (25/60 joints [41.7%] versus 0/15 joints
(p= 0.002).
3.3.2. US tenosynovitis in SSc and RA patients
Regarding US of the tendons, tenosynovitis was found in 18
SSc patients (45%) and 11 (36%) among RA patients
(Fig. 2). A total of 90 tendons with tenosynovitis were
detected, among the tendons with tenosynovitis, 81 (90%)
were characterized by a hyperechoic tendon sheath thickening,
a pattern considered as sclerosing. Sclerosing tenosynovitis
appeared to be speciﬁc to SSc patients (81/90 tendons in SSc
patients versus 0/16 tendons in RA patients (p< 0.001)
(Fig. 2). A power Doppler signal corresponding to an inﬂam-
matory pattern was detected in 45/90 tendons (50%) with
tenosynovitis. In addition 34 (37.7%) of 90 tendons with
tenosynovitis were both sclerosing and inﬂammatory. US
tenosynovitis occurred in patients with concomitant synovitis
in 4 (40%) of 10 cases.
Figure 1 Ultrasonographic image of the left wrist showing
synovitis with grade 1 PD signal.
Figure 4 Ultrasonographic image showing carpal erosions in a
patient with RA.
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in SSc and RA patients
Regarding US of the soft tissues, calciﬁcations were detected in
4 (10%) SSc and 2 (6.6%) RA patients (Fig. 3) but with no sta-
tistically signiﬁcant difference (p= 0.69). On the other hand
there was a statistical signiﬁcant difference between US hand
erosions and joint space narrowing in RA and SSc patients
(p< 0.001) (Fig. 4).Figure 3 Ultrasonographic image showing intra-articular calciﬁcatio
with SSc (right).
Figure 2 Ultrasonographic image (longitudinal section) showing inﬂ
RA (left) and sclerosing tenosynovitis in a patient with SSc (right).3.3.4. Relationship between ultrasonographic variables
with disease activity, clinical and radiological ﬁndings
In SSc patients, the prevalence of synovitis, tenosynovitis
detected by US was found to be higher than that found
by clinical examination (p= 0.01, p= 0.02 respectively),
while US tenosynovitis was more likely to occur in
patients with tendon friction rubs on clinical examination
(p= 0.04).n within the MCP joint in a patient with RA (left) and in a patient
ammatory tenosynovitis of the extensor tendons in a patient with
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statistically signiﬁcant correlation with the patient’s age
(p= 0.47), gender (p= 0.67), disease duration (p= 0.92),
Rheumatoid factor (p= 0.28), ESR (p= 0.15), CRP
(p= 0.36) or HAQ-DI (p= 0.14).
US in SSc patients showed a signiﬁcantly higher number of
joints with osteophytes than X-ray (p= 0.004), while only one
patient showing erosions detected by US and X-ray.
In RA patients, the prevalence of synovitis, tenosynovitis
detected by US was found to be higher than that found by clin-
ical examination (p= 0.02, p= 0.03, respectively).
US synovitis, tenosynovitis showed a statistically signiﬁcant
correlation with the ESR (p< 0.001, p= 0.002 respectively),
CRP (p< 0.001, p= 0.003 respectively) rheumatoid factor
(p= 0.02, p= 0.03 respectively), HAQ (p< 0.001 p< 0.001
respectively) and DAS28 (p< 0.001, p< 0.002 respectively).
However, a non-statistically signiﬁcant correlation was found
with the patient’s age (p= 0.14, p= 0.12), gender (p= 0.33,
p= 0.35) and disease duration (p= 0.76, p= 0.53).
On the other hand, US calcinosis showed a statistically sig-
niﬁcant correlation with the patient’s age (p< 0.001) and
DAS28 (p= 0.003). However, a non-statistically signiﬁcant
correlation was found with the patient’s gender (p= 1.0),
disease duration (p= 0.37), HAQ (p= 0.44), ESR, CRP
(p= 0.18, p= 0.43 respectively), and rheumatoid factor
(p= 1.0).
US in RA patients showed a signiﬁcantly higher number of
joints with joint space narrowing and erosions than X-rays
(p= 0.004, p= 0.003 respectively).4. Discussion
Our study enrolled 40 SSc and 30 RA patients. Our data
showed that US synovitis was found in 56% of the RA
patients in comparison to 43% with clinically detected articu-
lar manifestations and 25% of SSc patients in comparison to
15% of clinical synovitis which states clearly that US is more
sensitive than clinical examination in detecting joint swelling
in both RA and SSc patients. In keeping with our results, other
studies showed that US detects subclinical synovitis and path-
ological ﬁndings which are not detected clinically [28–32]. In
our study, US in SSc patients showed a signiﬁcantly higher
number of joints with osteophytes than X-rays (p= 0.004)
with only one patient showing erosions by US, while in RA
US showed a higher number of joints with joint space narrow-
ing and erosions than X-rays. These results are consistent with
published data [19,6]. In another Egyptian study on SSc
patients, hand disability was mainly related to impaired hand
mobility and also diminished strength. The use of US in
adjunct to clinical examination reﬁnes the evaluation of hand
impairment in these patients [33]. The reduced sensitivity of
US in detecting erosions in SSc patients is probably due to lim-
ited number of SSc patients with erosive disease and whether
an erosive arthritis is a part of the spectrum of scleroderma
or just an overlapping RA is still a matter of debate [34].
Power Doppler US has demonstrated a high sensitivity
(88.8%) and speciﬁcity (97.9%) for the assessment of inﬂam-
matory activity in the joints of patients compared with the
dynamic contrast enhanced MRI [35]. In the same way our
study showed inﬂammatory activity revealed by power
Doppler in 3 joints with synovitis in scleroderma patients.Positive intra-synovial power Doppler signal was signiﬁcantly
frequent in RA than SSc patients. A grade 2 or 3 power Dopp-
ler signal was more likely observed in RA patients compared to
grade 1 in SSc patients which indicates the articular difference
between the two groups. This coincides with the results of
studies carried out by other authors [36–38]. In RA patients
we found a signiﬁcant correlation between US detected synovi-
tis and the DAS28, ESR and CRP. In contrast, other studies
found that many RA patients who are regarded as having clin-
ically inactive disease still exhibit evidence of persistent synovi-
tis on US scanning [7] that appears predictive of worse
outcomes [4]. However, other studies suggested that radio-
graphic progression of patients in remission is largely restricted
to those who continue to exhibit clinical evidence of joint
inﬂammation (SJCP 2), since patients with an SJC 6 1 or in
sustained remission had minimal disease progression [39,40].
As regards tenosynovitis it was found in 18 SSc patients
(45%), among the tendons with tenosynovitis (90%) of them
were characterized by hyperechoic tendon sheath thickening
a pattern characteristic of sclerosing tenosynovitis more
observed in the extensor than ﬂexor tendons. Sclerosing teno-
synovitis appears to be speciﬁc for scleroderma patients com-
pared to RA patients. Again, this coincides with the results
of other authors [41] who stated that US tenosynovitis ﬁndings
in scleroderma do not correlate with disability and they
explained that by their patients having mildly severe tendon
affection as suggested by the low prevalence of tendon friction
rub. This unique pattern speciﬁc to scleroderma patients may
be an important way to suspect scleroderma in cases of diffuse
or uncertain articular manifestations where clinical examina-
tion may be insufﬁcient in detecting articular involvement
[36,38,42]. Regarding US of soft tissues, calciﬁcations were
detected in both scleroderma and RA patients (10%
and 6.6%) respectively, with no statistically signiﬁcant pattern,
these data are in accordance with previous studies that showed
calciﬁcations in SSc patients in about 10–50% of the patients
[43].
In conclusion, MSUS is not a substitute to history and
physical examination, US hand involvement in SSC and RA
can be more accurate than the single clinical examination.
US articular involvement in SSc is less frequent and is charac-
terized by mild inﬂammatory changes compared to that in RA,
with speciﬁc appearance of sclerosing tenosynovitis in SSc
patients more than RA. Further, larger prospective studies
are warranted to evaluate the importance of using US in the
follow up and assessment of SSc and RA patients.
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